174 related articles for article (PubMed ID: 31034365)
1. RTS,S malaria vaccine pilots in three African countries.
Adepoju P
Lancet; 2019 Apr; 393(10182):1685. PubMed ID: 31034365
[No Abstract] [Full Text] [Related]
2. Costs of continuing RTS,S/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countries.
Baral R; Levin A; Odero C; Pecenka C; Tabu C; Mwendo E; Bonsu G; Bawa J; Dadzie JF; Charo J; Antwi-Agyei KO; Amponsa-Achianou K; Jalango RE; Mkisi R; Gordon S; Mzengeza T; Morgan W; Muhib F
PLoS One; 2021; 16(1):e0244995. PubMed ID: 33428635
[TBL] [Abstract][Full Text] [Related]
3. Case reduction and cost-effectiveness of the RTS,S/AS01 malaria vaccine alongside bed nets in Lilongwe, Malawi.
Bell GJ; Loop M; Topazian HM; Hudgens M; Mvalo T; Juliano JJ; Kamthunzi P; Tegha G; Mofolo I; Hoffman I; Bailey JA; Emch M
Vaccine; 2020 May; 38(25):4079-4087. PubMed ID: 32362527
[TBL] [Abstract][Full Text] [Related]
4. Costing RTS,S introduction in Burkina Faso, Ghana, Kenya, Senegal, Tanzania, and Uganda: A generalizable approach drawing on publicly available data.
Galactionova K; Bertram M; Lauer J; Tediosi F
Vaccine; 2015 Nov; 33(48):6710-8. PubMed ID: 26518406
[TBL] [Abstract][Full Text] [Related]
5. Decision-making on malaria vaccine introduction: the role of cost-effectiveness analyses.
Moorthy VS; Hutubessy R; Newman RD; Hombach J
Bull World Health Organ; 2012 Nov; 90(11):864-6. PubMed ID: 23226899
[No Abstract] [Full Text] [Related]
6. Country specific predictions of the cost-effectiveness of malaria vaccine RTS,S/AS01 in endemic Africa.
Galactionova K; Tediosi F; Camponovo F; Smith TA; Gething PW; Penny MA
Vaccine; 2017 Jan; 35(1):53-60. PubMed ID: 27890400
[TBL] [Abstract][Full Text] [Related]
7. RTS,S malaria vaccine pilot studies: addressing the human realities in large-scale clinical trials.
van den Berg M; Ogutu B; Sewankambo NK; Biller-Andorno N; Tanner M
Trials; 2019 May; 20(1):316. PubMed ID: 31151473
[TBL] [Abstract][Full Text] [Related]
8. RTS,S: Toward a first landmark on the Malaria Vaccine Technology Roadmap.
Kaslow DC; Biernaux S
Vaccine; 2015 Dec; 33(52):7425-32. PubMed ID: 26431982
[TBL] [Abstract][Full Text] [Related]
9. Barriers and facilitators to nationwide implementation of the malaria vaccine in Ghana.
Adeshina OO; Nyame S; Milner J; Milojevic A; Asante KP
Health Policy Plan; 2023 Jan; 38(1):28-37. PubMed ID: 36083007
[TBL] [Abstract][Full Text] [Related]
10. The Future of the RTS,S/AS01 Malaria Vaccine: An Alternative Development Plan.
Gosling R; von Seidlein L
PLoS Med; 2016 Apr; 13(4):e1001994. PubMed ID: 27070151
[TBL] [Abstract][Full Text] [Related]
11. [Malaria vaccines--which vaccines to whom?].
Jepsen S
Tidsskr Nor Laegeforen; 2000 May; 120(14):1665-8. PubMed ID: 10901079
[TBL] [Abstract][Full Text] [Related]
12. Predictors of malaria vaccine uptake among children 6-24 months in the Kassena Nankana Municipality in the Upper East Region of Ghana.
Yeboah D; Owusu-Marfo J; Agyeman YN
Malar J; 2022 Nov; 21(1):339. PubMed ID: 36384655
[TBL] [Abstract][Full Text] [Related]
13. What Matters (and What Does Not) in Households' Decision to Invest in Malaria Prevention?
Dupas P
Am Econ Rev; 2009 May; 99(2):224-30. PubMed ID: 29505217
[No Abstract] [Full Text] [Related]
14. Policy challenges in malaria vaccine introduction.
Moree M; Ewart S
Am J Trop Med Hyg; 2004 Aug; 71(2 Suppl):248-52. PubMed ID: 15331844
[TBL] [Abstract][Full Text] [Related]
15. Advanced purchase commitments for a malaria vaccine.
Natl Bur Econ Res Bull Aging Health; 2005; (12):1-2. PubMed ID: 16175672
[No Abstract] [Full Text] [Related]
16. The Economics of Malaria Vaccine Development.
Plebanski M; Flanagan KL
Trends Parasitol; 2017 Mar; 33(3):154-156. PubMed ID: 28169112
[TBL] [Abstract][Full Text] [Related]
17. Malaria vaccine cautiously recommended for use in Africa.
Callaway E; Maxmen A
Nature; 2015 Oct; 526(7575):617-8. PubMed ID: 26511554
[No Abstract] [Full Text] [Related]
18. The evidence base on the cost-effectiveness of malaria control measures in Africa.
Goodman CA; Mills AJ
Health Policy Plan; 1999 Dec; 14(4):301-12. PubMed ID: 10787646
[TBL] [Abstract][Full Text] [Related]
19. The RTS,S/AS01 malaria vaccine in children 5 to 17 months of age at first vaccination.
Vandoolaeghe P; Schuerman L
Expert Rev Vaccines; 2016 Dec; 15(12):1481-1493. PubMed ID: 27841689
[TBL] [Abstract][Full Text] [Related]
20. Phase 3: RTS,S almost halves malaria cases in young children.
Riedmann EM
Hum Vaccin Immunother; 2013 Dec; 9(12):2501. PubMed ID: 24716207
[No Abstract] [Full Text] [Related]
[Next] [New Search]
